Thirty-day mortality after systemic anticancer treatment as a real-world, quality-of-care indicator: the Northland experience.

Thirty-day mortality rates were comparable to studies from larger institutions. We demonstrated the feasibility of this index for auditing practice in smaller oncology units over a longer timeframe.